We share your passion for science. Promega is committed to excellence in technologies to assess key processes in PROTAC-induced protein degradation: compound binding and permeability, ternary complex formation, ubiquitination, and trafficking to proteasome. Assay live cells in kinetic mode to determine target protein degradation rates, DC50 potency values, and recovery profiles. Let’s collaborate.
Ubiquigent Ltd is a unique enabler of ubiquitin system and protein degradation-based drug discovery. Our commercial models include FFS and FTE access and features our Collaborative Drug Discovery programme. We provide access to the necessary expertise, Drug Discovery Services, Chemistry (novel deubiquitylase – DUB – enzyme-focussed libraries) and high quality Research Tools… Read more
LifeSensors generates reagents and drug discovery platforms which enable researchers to accurately and effectively assay the Ubiquitin Proteasome System. In addition to off-the-shelf products and kits, LifeSensors also partners with companies and researchers around the world to develop novel drug discovery assays. LifeSensors’ powerful technologies in conjunction with our expertise in the UPS, have enabled researchers to target and assay the undruggable targets.